Companies › CCEL
CRYO-CELL INTL INC (CCEL)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000862692 · EDGAR filings · Updated 2026-07-15
CRYO-CELL INTL INC (CCEL) has reported institutional ownership of 6.6%, with 11 institutional managers holding positions valued at $1.89M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).
Latest updates
- 2026-07-15 — Quarterly report (10-Q) filed
- 2026-07-07 — SCHEDULE 13D/A filed
- 2026-05-29 — Insider transaction reported (Form 4)
- 2026-05-08 — Current report (8-K) filed
- 2026-04-14 — Quarterly report (10-Q) filed
- 2026-03-25 — SCHEDULE 13D filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, CRYO-CELL INTL INC has 11 institutional holders and institutional ownership of 6.6%.
Insider activity
Insiders reported 40 transactions (25 buys, 0 sells) across 6 reporting insiders, with a net reported value of $552.0K.
Data flags from SEC filings
Related companies
RADIOPHARM THERANOSTICS LTD (RADX) · PURETECH HEALTH PLC (PRTCY) · BIOFRONTERA INC (BFRI) · Dare Bioscience Inc (DARE) · Fresenius SE & Co KGaA (FSNUF) · NANOVIRICIDES INC (NNVC)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.